XOMA Corp (NASDAQ:XOMA)

24.48
Delayed Data
As of 4:00pm ET
 +0.27 / +1.12%
Today’s Change
5.86
Today|||52-Week Range
37.25
-31.24%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$193.1M

Company Description

XOMA Corp. engages in the discovery and development of innovative therapeutics derived from unique platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Berkeley, CA.

Contact Information

XOMA Corp.
2200 Powell Street
Emeryville California 94608
P:(510) 204-7200
Investor Relations:

Employees

Shareholders

Mutual fund holders8.50%
Other institutional34.01%
Individual stakeholders0.98%

Top Executives

James R. NealChief Executive Officer & Director
Thomas BurnsChief Financial Officer & Senior VP-Finance
F. Allan GordonVice President-Clinical
Danny J. HartVice President & General Counsel
Dee DattaChief Business Officer